Respana Therapeutics Revenue

Biotechnology Research • Philadelphia, Pennsylvania, United States • 1-10 Employees

Respana Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Respana Therapeutics

Kevin Harter

Chief Executive Officer

Company overview

Headquarters	3401 Market St., Suite 200, Philadelphia, Pennsylvania 19104, US
Website	respanatx.com
Keywords	Ards, Respiratory Therapies, Influenza Complications, Pneumonia Complications
Founded	2017
Employees	1-10

Respana Therapeutics Email Formats

Respana Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@respanatx.com), used 66.7% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@respanatx.com	66.7%
{first initial}{last name}	jdoe@respanatx.com	33.3%

About Respana Therapeutics

Respana Therapeutics is a preclinical-stage company developing therapeutics that modulate immune response. Our initial target is the significant morbidity and mortality associated with post-infectious pulmonary complications.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Respana Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Respana Therapeutics has never raised funding before.

Respana Therapeutics Tech Stack

Discover the technologies and tools that power Respana Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

reCAPTCHA

Security

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

BoldGrid

Blogs

PHP

Programming languages

HSTS

Security

Stimulus

JavaScript frameworks

WordPress

Blogs

Yoast SEO

SEO

Frequently asked questions

Respana Therapeutics is located in Philadelphia, Pennsylvania, US.

Respana Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Respana Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Respana Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Respana Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Respana Therapeutics

Kevin Harter

Chief Executive Officer

4.8

40,000 users